J. bras. pneumol. vol.41 número4

A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresec-

Prognostic significance of metastases to mediastinal lymph node levels in resected non small cell lung carcinoma.. Surgery for stage IIIA-N2 non small cell

rad i otherapy followed by surgery for stages III A (N2) and III B non-small-cell lung cancer: mature results of Southwest.. Oncology Group phase II study

In a previous study of cases of stage I non-small cell lung cancer (NSCLC), we also reported significant gender-related differences in long-term survival, with better rates

Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients.. Bernd Schmidt 1 , Julia

Non-Hodgkin’s lymphoma of the brain: Can high dose large volume radiation therapy improve sur- vival. Report on a prospective trial by the Radiation Therapy Oncology Group

Objectives: To determine differences in overall survival and quality of life among patients with stage IV non-small cell lung cancer non-metastatic to the brain treated with